HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $172,000 | +63.8% | 6,541 | +20.7% | 0.00% | – |
| Q4 2018 | $105,000 | +208.8% | 5,420 | +211.5% | 0.00% | – |
| Q3 2018 | $34,000 | -80.5% | 1,740 | -85.9% | 0.00% | -100.0% |
| Q1 2018 | $174,000 | -67.8% | 12,300 | -71.2% | 0.01% | -63.6% |
| Q3 2017 | $541,000 | +79.7% | 42,718 | +68.3% | 0.02% | +69.2% |
| Q2 2017 | $301,000 | -61.8% | 25,377 | -41.5% | 0.01% | -75.5% |
| Q3 2016 | $787,000 | -24.5% | 43,409 | -31.4% | 0.05% | -24.3% |
| Q2 2016 | $1,042,000 | -39.8% | 63,291 | -20.8% | 0.07% | -48.5% |
| Q4 2015 | $1,732,000 | +509.9% | 79,959 | +457.6% | 0.14% | +547.6% |
| Q3 2015 | $284,000 | +305.7% | 14,339 | +605.3% | 0.02% | +250.0% |
| Q2 2015 | $70,000 | +6900.0% | 2,033 | +3966.0% | 0.01% | – |
| Q1 2015 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |